[PERSON]

Retatrutide

Featured in 3 tracked stories · first seen 2 months ago

Situations

[ACTIVE] [HEALTH] [US] [CN] [SA]

Retatrutide investigational drug development and safety

4 clusters · 9 sources · last updated about 8 hours ago

Latest: Saudi FDA warns against unapproved use of Retatrutide

Retatrutide, an investigational synthetic peptide developed by Eli Lilly (also known by the code LY3437943), is being studied for its metabolic potential in managing food regulation, sugar, and weight. As a triple recept

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

314 clusters · 1158 sources · last updated 1 day ago

Latest: GLP-1 medications and weight management strategies

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Cardiovascular benefits rema